Document ID: FDA-2013-N-0001-0035
Agency: fda
Document Type: Notice
Title: 2013 Medical Countermeasures Initiative Regulatory Science Symposium
Posted Date: 2013-04-05T04:00Z

[Federal Register Volume 78, Number 66 (Friday, April 5, 2013)]
[Notices]
[Page 20664]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-07893]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2013-N-0001]

2013 Medical Countermeasures Initiative Regulatory Science 
Symposium

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA) is announcing the following 
meeting: 2013 Medical Countermeasures initiative (MCMi) Regulatory 
Science Symposium. The symposium is intended to provide a forum for the 
exchange of ideas for medical countermeasure development, highlight 
work on regulatory science as it applies to the development and 
advancement of medical countermeasures, facilitate innovative 
directions, and inform stakeholders on medical countermeasure-related 
scientific progress and accomplishments.
    Dates and Times: The symposium will be held on May 29 and May 30, 
2013, from 9 a.m. to 5 p.m., and on May 31, 2013, from 9 a.m. to 12 
noon. Persons interested in attending the symposium in person or 
viewing via Webcast must register by May 24, 2013, at 5 p.m. EST.
    Location: The symposium will be held at the FDA White Oak Campus, 
10903 New Hampshire Ave., Bldg. 31 Conference Center, the Great Room 
(Rm. 1503), Silver Spring, MD 20993-0002. Entrance for the symposium 
participants (non-FDA employees) is through Building 1 where routine 
security check procedures will be performed. For parking and security 
information, please refer to http://www.fda.gov/AboutFDA/WorkingatFDA/BuildingsandFacilities/WhiteOakCampusInformation/ucm241740.htm.
    Contact: Rakesh Raghuwanshi, Office of Counterterrorism and 
Emerging Threats, Food and Drug Administration, 10903 New Hampshire 
Ave., Bldg. 32, Rm. 4283, Silver Spring, MD 20993, 301-796-4769, Fax: 
301-847-8615, email: AskMCMi@fda.hhs.gov.
    Registration: If you wish to attend the symposium or view via 
Webcast, you must register at http://www.fda.gov/medicalcountermeasures 
by May 24, 2013, at 5 p.m. EST. When registering, you must provide the 
following information: (1) Your name, (2) title, (3) company or 
organization (if applicable), (4) mailing address, (5) phone number, 
and (6) email address.
    There is no fee to register for the symposium and registration will 
be on a first-come, first-served basis. Early registration is 
recommended because seating is limited.
    If you need special accommodations due to a disability, please 
enter pertinent information in the ``Notes'' section of the electronic 
registration form when you register.

    Date: April 1, 2013.
Peter Lurie,
Acting Associate Commissioner for Policy and Planning.
[FR Doc. 2013-07893 Filed 4-4-13; 8:45 am]
BILLING CODE 4160-01-P